32 / 534
MEDICINE
•
Larger portfolio, though P&E’s ME list
has greater depth and curriculum
coverage.
•
Elsevier focus is almost exclusively on
institutional sales via Clinical Key
•
Sunsetting both MD Consult and Expert
Consult and have replatformed Expert
Consult on Inkling to support sales to
individuals.
•
Aggressively transforming business
from individual to institutional: new
technology platform (Clinical Key),
marketing and sales (eliminated PSG
reps and used heads for CK), editorial
(acquisition editors now content
specialists focused on filling CK gaps).
•
P&E content generally broader and
deeper in both Med Practice and Med
Ed. P&E lacks a core reference in
Internal Medicine to compete with
Harrison’s; M-H also has stronger
position in USMLE and other Med Ed
review.
•
Mature institutional offerings with
Access series; Access products recently
replatformed.
•
Moving into CDS with launch of Clinical
Access.
•
A number of focused niche players have
emerged to serve the unmet needs of
specific specialty areas (e.g., Pathoma
in Medical Education course review;
Orthobullets in Orthopedic Surgery
residency education).
Implications for WK
Implications for WK
Implications for WK
•
Elsevier’s pivot toward Clinical Decision
Support leaves open space in medical
learning, but P&E needs strong
institutional capabilities quickly to
succeed (platform, product, marketing
and sales).
•
M-H is limited by the size and narrower
focus of Medical portfolio. M-H,
however does publish in areas where
WK is strong ; thus, they are ahead of
us with institutional specialty offerings
in Anesthesiology, Surgery. WK needs
similar specialty-specific offerings or
risks losing dominant market position.
Collections in Health Library should
counter the threat.
•
While these players are small, they
have the potential to disintermediate
WK in key specialty areas. WK should
accelerate offerings in specialties where
niche players are gaining ground and/or
look at acquiring them.
While traditional competitors in Medicine are focusing on Clinical
Decision Support to compete with UTD; non-traditional players are a
potential threat
Niche Startups
7